---
schema_version: "secwatch.filing_event.v1"
accession: "0001397702-23-000061"
form_type: "8-K"
ticker: null
cik: "0001397702"
company_name: "Silk Road Medical Inc"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-08T23:47:24.891162+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Silk Road Medical names Chas McKhann CEO effective Nov 2, 2023; Erica Rogers retires

## Summary
- Chas McKhann appointed CEO and director effective November 2, 2023, succeeding Erica Rogers who retired.
- McKhann receives $650K base salary, $100K sign-on bonus, target bonus of 100% of salary.
- McKhann granted 612,083 RSUs (4-year vesting) and 612,083 PSUs (relative TSR performance vesting).
- Rogers enters consulting agreement for one year at $55K/month; her PSUs forfeited, RSUs accelerate, option extension.

## SEC filing metadata
- accession: 0001397702-23-000061
- form_type: 8-K
- cik: 0001397702
- company_name: Silk Road Medical Inc
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1397702/000139770223000061/0001397702-23-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1397702/000139770223000061/silk-20231102x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001397702-23-000061
- JSON: https://secwatch.observer/filing/0001397702-23-000061.json
- Plain text: https://secwatch.observer/filing/0001397702-23-000061.txt

## Key facts
- Executive change
  Charles (Chas) McKhann was appointed as Chief Executive Officer at Silk Road Medical Inc.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On November 2, 2023, Silk Road Medical, Inc. (the “Company”) announced the appointment of Charles (Chas) McKhann as Chief Executive Officer (“CEO”) and a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1397702/000139770223000061/0001397702-23-000061-index.htm
- Executive change
  Erica J. Rogers retired as President and Chief Executive Officer at Silk Road Medical Inc.
  - Action: retired
  - Role: President and Chief Executive Officer
  source text: Mr. McKhann will succeed Erica J. Rogers, who is retiring, effective November 2, 2023, and has served on the Company’s Board of Directors and as President and Chief Executive Officer for over 11 years.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1397702/000139770223000061/0001397702-23-000061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.